Neoplasm by Site — Trials

Neoplasm by Site — Trials · CancerIndex

Clinical trials

Registered studies

92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 451–500 of 13,594 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04696809	A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma	completed	Phase 1 / Phase 2	40	Janssen Pharmaceutical K.K.INDUSTRY	1	Jun 5, 2026	clinicaltrials
NCT04848974	Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia	completed	Phase 1 / Phase 2	37	M.D. Anderson Cancer CenterOTHER	1	Jun 5, 2026	clinicaltrials